BCL6 and diffuse large B-cell lymphoma: CRISPR/Cas9-mediated ablation of BCL6 in DLBCL cell lines caused G1 cell cycle arrest but no apoptosis (55) suggesting that on-target BCL6 inhibition may indeed not cause cell line apoptosis.